2BBBullish & Bearish
Soleno Therapeutics, Inc. (SLNO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 31 out of 100.
Soleno Therapeutics, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 0 | Strongly Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-08-06 | — | 0.9563 | — | $115.12M |
| 2026-05-07 | 0.59 | 0.6936 | $94.60M | $95.29M |
| 2026-02-25 | 0.8 | 0.725 | $91.73M | $90.32M |